0001127602-22-014966.txt : 20220518 0001127602-22-014966.hdr.sgml : 20220518 20220518163444 ACCESSION NUMBER: 0001127602-22-014966 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220516 FILED AS OF DATE: 20220518 DATE AS OF CHANGE: 20220518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DArecca James CENTRAL INDEX KEY: 0001583903 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 22939644 MAIL ADDRESS: STREET 1: C/O HAEMONETICS CORPORATION STREET 2: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0402 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-05-16 0000313143 HAEMONETICS CORP HAE 0001583903 DArecca James 125 SUMMER STREET BOSTON MA 02110 1 EVP, Chief Financial Officer Common Stock 2022-05-16 4 A 0 4774 A 10676 D Non-qualified Stock Option (Right to Buy) 57.60 2022-05-16 4 A 0 11163 0 A 2029-05-16 Common Stock 11163 11163 D The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. This number includes unvested RSUs previously reported. Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. /s/ Thomas V. Powers, attorney-in-fact for Mr. D'Arecca 2022-05-18